5 Primary · 12 Secondary · Reporting Duration: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
100 Total Participants · 2 Treatment Groups
Primary Treatment: STEP-COVID · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.